- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Measles and Rubella Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Measles and Rubella Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Measles and Rubella Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Measles and Rubella Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Measles and Rubella Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Measles and Rubella Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Measles and Rubella Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Measles and Rubella Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Measles and Rubella Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monovalent Vaccines
Multivalent Vaccines
Market segment by Application
Hospital
Clinic
Others
Major players covered
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles and Rubella Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles and Rubella Vaccines, with price, sales, revenue and global market share of Measles and Rubella Vaccines from 2018 to 2023.
Chapter 3, the Measles and Rubella Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles and Rubella Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Measles and Rubella Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles and Rubella Vaccines.
Chapter 14 and 15, to describe Measles and Rubella Vaccines sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Measles and Rubella Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles and Rubella Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monovalent Vaccines
1.3.3 Multivalent Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles and Rubella Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Measles and Rubella Vaccines Market Size & Forecast
1.5.1 Global Measles and Rubella Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Measles and Rubella Vaccines Sales Quantity (2018-2029)
1.5.3 Global Measles and Rubella Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Serum Institute of India Ltd.
2.1.1 Serum Institute of India Ltd. Details
2.1.2 Serum Institute of India Ltd. Major Business
2.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Product and Services
2.1.4 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Serum Institute of India Ltd. Recent Developments/Updates
2.2 Merck & Co. Inc.
2.2.1 Merck & Co. Inc. Details
2.2.2 Merck & Co. Inc. Major Business
2.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Product and Services
2.2.4 Merck & Co. Inc. Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co. Inc. Recent Developments/Updates
2.3 GlaxoSmithKline Inc.
2.3.1 GlaxoSmithKline Inc. Details
2.3.2 GlaxoSmithKline Inc. Major Business
2.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product and Services
2.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Inc. Recent Developments/Updates
2.4 Takeda Pharmaceutical Company
2.4.1 Takeda Pharmaceutical Company Details
2.4.2 Takeda Pharmaceutical Company Major Business
2.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product and Services
2.4.4 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
3 Competitive Environment: Measles and Rubella Vaccines by Manufacturer
3.1 Global Measles and Rubella Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Measles and Rubella Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Measles and Rubella Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Measles and Rubella Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Measles and Rubella Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Measles and Rubella Vaccines Manufacturer Market Share in 2022
3.5 Measles and Rubella Vaccines Market: Overall Company Footprint Analysis
3.5.1 Measles and Rubella Vaccines Market: Region Footprint
3.5.2 Measles and Rubella Vaccines Market: Company Product Type Footprint
3.5.3 Measles and Rubella Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Measles and Rubella Vaccines Market Size by Region
4.1.1 Global Measles and Rubella Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Measles and Rubella Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Measles and Rubella Vaccines Average Price by Region (2018-2029)
4.2 North America Measles and Rubella Vaccines Consumption Value (2018-2029)
4.3 Europe Measles and Rubella Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Measles and Rubella Vaccines Consumption Value (2018-2029)
4.5 South America Measles and Rubella Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Measles and Rubella Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Measles and Rubella Vaccines Consumption Value by Type (2018-2029)
5.3 Global Measles and Rubella Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Measles and Rubella Vaccines Consumption Value by Application (2018-2029)
6.3 Global Measles and Rubella Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Measles and Rubella Vaccines Market Size by Country
7.3.1 North America Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Measles and Rubella Vaccines Market Size by Country
8.3.1 Europe Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Measles and Rubella Vaccines Market Size by Region
9.3.1 Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Measles and Rubella Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Measles and Rubella Vaccines Market Size by Country
10.3.1 South America Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Measles and Rubella Vaccines Market Size by Country
11.3.1 Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Measles and Rubella Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Measles and Rubella Vaccines Market Drivers
12.2 Measles and Rubella Vaccines Market Restraints
12.3 Measles and Rubella Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Measles and Rubella Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles and Rubella Vaccines
13.3 Measles and Rubella Vaccines Production Process
13.4 Measles and Rubella Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles and Rubella Vaccines Typical Distributors
14.3 Measles and Rubella Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Measles and Rubella Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Measles and Rubella Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Serum Institute of India Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Serum Institute of India Ltd. Major Business
Table 5. Serum Institute of India Ltd. Measles and Rubella Vaccines Product and Services
Table 6. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Serum Institute of India Ltd. Recent Developments/Updates
Table 8. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co. Inc. Major Business
Table 10. Merck & Co. Inc. Measles and Rubella Vaccines Product and Services
Table 11. Merck & Co. Inc. Measles and Rubella Vaccines Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck & Co. Inc. Recent Developments/Updates
Table 13. GlaxoSmithKline Inc. Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Inc. Major Business
Table 15. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product and Services
Table 16. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Inc. Recent Developments/Updates
Table 18. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 19. Takeda Pharmaceutical Company Major Business
Table 20. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product and Services
Table 21. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Takeda Pharmaceutical Company Recent Developments/Updates
Table 23. Global Measles and Rubella Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 24. Global Measles and Rubella Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Measles and Rubella Vaccines Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 26. Market Position of Manufacturers in Measles and Rubella Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Measles and Rubella Vaccines Production Site of Key Manufacturer
Table 28. Measles and Rubella Vaccines Market: Company Product Type Footprint
Table 29. Measles and Rubella Vaccines Market: Company Product Application Footprint
Table 30. Measles and Rubella Vaccines New Market Entrants and Barriers to Market Entry
Table 31. Measles and Rubella Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Measles and Rubella Vaccines Sales Quantity by Region (2018-2023) & (K Doses)
Table 33. Global Measles and Rubella Vaccines Sales Quantity by Region (2024-2029) & (K Doses)
Table 34. Global Measles and Rubella Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Measles and Rubella Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Measles and Rubella Vaccines Average Price by Region (2018-2023) & (US$/Dose)
Table 37. Global Measles and Rubella Vaccines Average Price by Region (2024-2029) & (US$/Dose)
Table 38. Global Measles and Rubella Vaccines Sales Quantity by Type (2018-2023) & (K Doses)
Table 39. Global Measles and Rubella Vaccines Sales Quantity by Type (2024-2029) & (K Doses)
Table 40. Global Measles and Rubella Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Measles and Rubella Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Measles and Rubella Vaccines Average Price by Type (2018-2023) & (US$/Dose)
Table 43. Global Measles and Rubella Vaccines Average Price by Type (2024-2029) & (US$/Dose)
Table 44. Global Measles and Rubella Vaccines Sales Quantity by Application (2018-2023) & (K Doses)
Table 45. Global Measles and Rubella Vaccines Sales Quantity by Application (2024-2029) & (K Doses)
Table 46. Global Measles and Rubella Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Measles and Rubella Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Measles and Rubella Vaccines Average Price by Application (2018-2023) & (US$/Dose)
Table 49. Global Measles and Rubella Vaccines Average Price by Application (2024-2029) & (US$/Dose)
Table 50. North America Measles and Rubella Vaccines Sales Quantity by Type (2018-2023) & (K Doses)
Table 51. North America Measles and Rubella Vaccines Sales Quantity by Type (2024-2029) & (K Doses)
Table 52. North America Measles and Rubella Vaccines Sales Quantity by Application (2018-2023) & (K Doses)
Table 53. North America Measles and Rubella Vaccines Sales Quantity by Application (2024-2029) & (K Doses)
Table 54. North America Measles and Rubella Vaccines Sales Quantity by Country (2018-2023) & (K Doses)
Table 55. North America Measles and Rubella Vaccines Sales Quantity by Country (2024-2029) & (K Doses)
Table 56. North America Measles and Rubella Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Measles and Rubella Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Measles and Rubella Vaccines Sales Quantity by Type (2018-2023) & (K Doses)
Table 59. Europe Measles and Rubella Vaccines Sales Quantity by Type (2024-2029) & (K Doses)
Table 60. Europe Measles and Rubella Vaccines Sales Quantity by Application (2018-2023) & (K Doses)
Table 61. Europe Measles and Rubella Vaccines Sales Quantity by Application (2024-2029) & (K Doses)
Table 62. Europe Measles and Rubella Vaccines Sales Quantity by Country (2018-2023) & (K Doses)
Table 63. Europe Measles and Rubella Vaccines Sales Quantity by Country (2024-2029) & (K Doses)
Table 64. Europe Measles and Rubella Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Measles and Rubella Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Type (2018-2023) & (K Doses)
Table 67. Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Type (2024-2029) & (K Doses)
Table 68. Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Application (2018-2023) & (K Doses)
Table 69. Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Application (2024-2029) & (K Doses)
Table 70. Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Region (2018-2023) & (K Doses)
Table 71. Asia-Pacific Measles and Rubella Vaccines Sales Quantity by Region (2024-2029) & (K Doses)
Table 72. Asia-Pacific Measles and Rubella Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Measles and Rubella Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Measles and Rubella Vaccines Sales Quantity by Type (2018-2023) & (K Doses)
Table 75. South America Measles and Rubella Vaccines Sales Quantity by Type (2024-2029) & (K Doses)
Table 76. South America Measles and Rubella Vaccines Sales Quantity by Application (2018-2023) & (K Doses)
Table 77. South America Measles and Rubella Vaccines Sales Quantity by Application (2024-2029) & (K Doses)
Table 78. South America Measles and Rubella Vaccines Sales Quantity by Country (2018-2023) & (K Doses)
Table 79. South America Measles and Rubella Vaccines Sales Quantity by Country (2024-2029) & (K Doses)
Table 80. South America Measles and Rubella Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Measles and Rubella Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Type (2018-2023) & (K Doses)
Table 83. Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Type (2024-2029) & (K Doses)
Table 84. Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Application (2018-2023) & (K Doses)
Table 85. Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Application (2024-2029) & (K Doses)
Table 86. Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Region (2018-2023) & (K Doses)
Table 87. Middle East & Africa Measles and Rubella Vaccines Sales Quantity by Region (2024-2029) & (K Doses)
Table 88. Middle East & Africa Measles and Rubella Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Measles and Rubella Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Measles and Rubella Vaccines Raw Material
Table 91. Key Manufacturers of Measles and Rubella Vaccines Raw Materials
Table 92. Measles and Rubella Vaccines Typical Distributors
Table 93. Measles and Rubella Vaccines Typical Customers
List of Figures
Figure 1. Measles and Rubella Vaccines Picture
Figure 2. Global Measles and Rubella Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Measles and Rubella Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Monovalent Vaccines Examples
Figure 5. Multivalent Vaccines Examples
Figure 6. Global Measles and Rubella Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Measles and Rubella Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Measles and Rubella Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Measles and Rubella Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Measles and Rubella Vaccines Sales Quantity (2018-2029) & (K Doses)
Figure 14. Global Measles and Rubella Vaccines Average Price (2018-2029) & (US$/Dose)
Figure 15. Global Measles and Rubella Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Measles and Rubella Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Measles and Rubella Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Measles and Rubella Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Measles and Rubella Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Measles and Rubella Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Measles and Rubella Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Measles and Rubella Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Measles and Rubella Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Measles and Rubella Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Measles and Rubella Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Measles and Rubella Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Measles and Rubella Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Measles and Rubella Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Measles and Rubella Vaccines Average Price by Type (2018-2029) & (US$/Dose)
Figure 30. Global Measles and Rubella Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Measles and Rubella Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Measles and Rubella Vaccines Average Price by Application (2018-2029) & (US$/Dose)
Figure 33. North America Measles and Rubella Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Measles and Rubella Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Measles and Rubella Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Measles and Rubella Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Measles and Rubella Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Measles and Rubella Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Measles and Rubella Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Measles and Rubella Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Measles and Rubella Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Measles and Rubella Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Measles and Rubella Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Measles and Rubella Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Measles and Rubella Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Measles and Rubella Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Measles and Rubella Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Measles and Rubella Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Measles and Rubella Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Measles and Rubella Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Measles and Rubella Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Measles and Rubella Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Measles and Rubella Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Measles and Rubella Vaccines Market Drivers
Figure 74. Measles and Rubella Vaccines Market Restraints
Figure 75. Measles and Rubella Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Measles and Rubella Vaccines in 2022
Figure 78. Manufacturing Process Analysis of Measles and Rubella Vaccines
Figure 79. Measles and Rubella Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
